デフォルト表紙
市場調査レポート
商品コード
1630723

医療用インプラント市場の規模、シェア、成長分析、製品タイプ別、生体材料タイプ別、地域別 - 産業予測、2025~2032年

Medical Implants Market Size, Share, Growth Analysis, By Product Type (Orthopedic Implants, Cardiovascular Implants), By Biomaterial Type (Metallic Biomaterials, Ceramic Biomaterials), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療用インプラント市場の規模、シェア、成長分析、製品タイプ別、生体材料タイプ別、地域別 - 産業予測、2025~2032年
出版日: 2025年01月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用インプラントの世界市場規模は2023年に964億4,000万米ドルとなり、予測期間(2025-2032年)のCAGRは6.8%で、2024年の1,030億米ドルから2032年には1,743億4,000万米ドルに成長する見通しです。

世界の医療用インプラント市場には、生体構造を置換または支持するために移植される装置や組織が含まれるが、慢性疾患の増加と高齢化により大きく進化しています。整形外科疾患、心血管疾患、神経疾患からの解放を求める患者の増加に伴い、革新的な移植可能ソリューションへの需要が高まっています。市場の成長は、技術の進歩と低侵襲手術技術によってさらに促進されます。しかし、高額な手術費用、限られた保険適用範囲、厳しい規制、感染症やインプラントの不具合などの合併症といった課題も依然として残っています。このようなハードルにもかかわらず、3D プリンティング、生体適合性材料、デジタルヘルスケア統合などのイノベーションにはチャンスが豊富にあり、カスタマイズされたインプラントと患者の転帰の改善への道が開かれています。既存の課題を克服し、市場の可能性を高めるためには、継続的な調査と技術革新が不可欠です。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

医療用インプラント市場規模:製品タイプ別

  • 市場概要
  • 整形外科用インプラント
    • 再建関節置換術
    • 膝関節置換インプラント
    • 股関節置換インプラント
    • 四肢
    • オーソバイオロジクス
    • 外傷および頭蓋顎顔面
  • 心臓血管インプラント
    • ペーシングデバイス
    • 心臓再同期療法装置(CRT)
    • CRT-P(ペースメーカー機能付きCRT)
    • CRT-D(ペースメーカーとICD機能を備えたCRT)
    • 植込み型除細動器(ICD)
    • 経静脈植込み型除細動器(T-ICD)
    • 皮下植込み型除細動器(S-ICD)
    • 植込み型心臓ペースメーカー(ICP)
  • ステント
    • 冠動脈ステント
    • 薬剤溶出ステント(DES)
    • ベアメタル冠動脈ステント
    • 生体吸収性ステント
    • 末梢ステント
    • 腸骨
    • 大腿膝窩
    • 腎臓
    • 頚動脈
    • ステント関連インプラント
    • 合成移植片
    • 大静脈フィルター
  • 構造的心臓インプラント
    • 人工心臓弁
    • 埋め込み型補助人工心臓
    • LVAD
    • RVAD
    • BIVAD
  • 脊椎インプラント
    • 脊椎固定インプラント
    • 脊椎骨刺激装置
    • 脊椎圧迫骨折(VCF)デバイス
    • 運動保存装置/非融合装置
  • 神経刺激装置
    • 脳深部刺激療法(DBS)
    • 仙骨神経刺激(SNS)
    • 迷走神経刺激(VNS)
    • 脊髄刺激療法(SCS)
    • その他の神経刺激装置
  • 眼科インプラント
    • 眼内レンズ
    • 緑内障インプラント
  • 歯科インプラント
    • プレート型歯科インプラント
    • ルートフォーム歯科インプラント
  • 顔面インプラント
  • 乳房インプラント

医療用インプラント市場規模:生体材料タイプ別

  • 市場概要
  • 金属バイオマテリアル
  • セラミックバイオマテリアル
  • ポリマーバイオマテリアル
  • 天然バイオマテリアル

医療用インプラント市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Medtronic plc(Ireland)
  • Johnson & Johnson(United States)
  • Abbott Laboratories(United States)
  • Stryker Corporation(United States)
  • Boston Scientific Corporation(United States)
  • Zimmer Biomet Holdings, Inc.(United States)
  • Smith & Nephew plc(United Kingdom)
  • Edwards Lifesciences Corporation(United States)
  • Globus Medical, Inc.(United States)
  • Integra LifeSciences Holdings Corporation(United States)
  • Orthofix Medical Inc.(United States)
  • LivaNova PLC(United Kingdom)
  • Penumbra, Inc.(United States)
  • Glaukos Corporation(United States)
  • Nevro Corp.(United States)
  • Axogen, Inc.(United States)
  • SI-BONE, Inc.(United States)

結論と推奨事項

目次
Product Code: SQMIG35H2125

Global Medical Implants Market size was valued at USD 96.44 billion in 2023 and is poised to grow from USD 103.0 billion in 2024 to USD 174.34 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The global medical implants market, which includes devices and tissues implanted to replace or support biological structures, is evolving significantly due to rising chronic conditions and an aging population. As patients increasingly seek relief from orthopedic, cardiovascular, and neurological disorders, the demand for innovative implantable solutions is on the rise. Market growth is further propelled by technological advancements and minimally invasive surgical techniques. However, challenges persist, including high procedure costs, limited insurance coverage, stringent regulations, and complications like infections and implant failures. Despite these hurdles, opportunities abound with innovations such as 3D printing, biocompatible materials, and digital healthcare integration, paving the way for customized implants and improved patient outcomes. Continuous research and innovation are crucial for overcoming existing challenges and enhancing market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Implants Market Segmental Analysis

Global Medical Implants Market is segmented by Product Type, Biomaterial Type and region. Based on Product Type, the market is segmented into Orthopedic Implants, Cardiovascular Implants, Stents, Structural Cardiac Implants, Spinal Implants, Neurostimulators, Opthalmic Implants, Dental Implants, Facial Implants and Breast Implants. Based on Biomaterial Type, the market is segmented into Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials and Natural Biomaterials. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Medical Implants Market

The growth of the global medical implants market is significantly propelled by remarkable technological advancements. For instance, the launch of robotic-assisted surgical systems for joint replacement in 2022 has revolutionized surgical precision, leading to reduced recovery periods and enhanced patient outcomes. These innovations not only optimize complex implant surgeries but also capture the interest of both patients and healthcare providers alike. As technology progresses, it continues to broaden the horizons for various implant procedures, solidifying the market's expansion and further augmenting confidence in the efficacy of medical implants across the healthcare landscape.

Restraints in the Global Medical Implants Market

One of the primary restraints affecting the Global Medical Implants market is the high cost associated with these devices. The expenses related to implant materials, surgical interventions, and post-operative care can pose significant barriers to patient access, especially in areas with restricted healthcare infrastructure or insufficient insurance benefits. This challenge surrounding the affordability of medical implants continues to impede their broader acceptance and utilization, ultimately constraining market expansion. As a result, the financial burden of medical implants remains a critical factor that must be addressed to enhance accessibility and support growth within the industry.

Market Trends of the Global Medical Implants Market

The Global Medical Implants market is increasingly influenced by the rising trend of minimally invasive procedures, which gained momentum in 2022. Techniques like laparoscopy and arthroscopy are redefining surgical approaches by providing significant advantages, including smaller incisions, minimal scarring, faster recovery, and lowered risk of postoperative complications. This growing preference for less invasive techniques has spurred innovation in specialized implants and instrumentation, allowing for tailored, patient-centric treatment options. As healthcare professionals and patients continue to prioritize enhanced safety and efficiency, the market for medical implants is expected to expand, aligning with advancements in procedures and technologies that emphasize minimally invasive solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Medical Implants Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Orthopedic Implants
    • Reconstructive Joint Replacements
    • Knee Replacement Implants
    • Hip Replacement Implants
    • Extremities
    • Orthobiologics
    • Trauma & Craniomaxillofacial
  • Cardiovascular Implants
    • Pacing Devices
    • Cardiac Resynchronization Therapy Devices (CRTs)
    • CRT-P (CRT with pacemaker function)
    • CRT-D (CRT with pacemaker and ICD function)
    • Implantable Cardioverter Defibrillators (ICDs)
    • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
    • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
    • Implantable Cardioc Pacemakers (ICPs)
  • Stents
    • Coronary stents
    • Drug-eluting Stents (DES)
    • Bare-metal Coronary Stents
    • Bioabsorbable Stents
    • Peripheral stents
    • Iliac
    • Femoral-Popliteal
    • Renal
    • Carotid
    • Stent-related Implants
    • Synthetic Grafts
    • Vena Cava Filters
  • Structural Cardiac Implants
    • Mechanical Heart Valves
    • Implantable Ventricular-assist Devices
    • LVAD
    • RVAD
    • BIVAD
  • Spinal Implants
    • Spinal fusion implants
    • Spinal bone stimulators
    • Vertebral Compression Fracture (VCF) Devices
    • Motion Preservation Devices/Non-Fusion Devices
  • Neurostimulators
    • Deep Brain Stimulation (DBS)
    • Sacral Nerve Stimulation (SNS)
    • Vagus Nerve Stimulation (VNS)
    • Spinal Cord Stimulation (SCS)
    • Other neurostimulators
  • Opthalmic Implants
    • Intraocular Lens
    • Glaucoma Implants
  • Dental Implants
    • Plate Form Dental Implants
    • Root Form Dental Implants
  • Facial Implants
  • Breast Implants

Global Medical Implants Market Size by Biomaterial Type & CAGR (2025-2032)

  • Market Overview
  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Natural Biomaterials

Global Medical Implants Market Size & CAGR (2025-2032)

  • North America (Product Type, Biomaterial Type)
    • US
    • Canada
  • Europe (Product Type, Biomaterial Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Biomaterial Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Biomaterial Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Biomaterial Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Globus Medical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthofix Medical Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glaukos Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Axogen, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SI-BONE, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations